Medical Marijuana, Inc. subsidiary HempMeds® was mentioned in an article by CFN Media covering a recent cannabis industry report by Brightfield Group.
In an article this week covering the rapidly growing CBD oil market, CFN Media focused on Medical Marijuana, Inc., and its portfolio company HempMeds®, and their role as the first company to retail CBD hemp oil products across state lines and to international markets.
According to the article, the CBD oil industry is predicted to hit $1 billion by 2020. That means the CBD market will experience 55% compounded growth over the next three years. While the CBD oil market isn’t predicted to eclipse the marijuana market, CBD oil does have the advantage of being federally legal in all 50 states and in over 40 countries internationally.
The Brightfield Group report listed HempMeds® distributed Real Scientific Hemp Oil™ (RSHO™) as one of the top five CBD oil brands in the industry. As a leader in the CBD oil industry, Medical Marijuana, Inc. continues to innovate our CBD oil pipeline and bring access to our products to new markets around the world.
CFN Media detailed the expansion of RSHO™ into new markets like Brazil and Mexico. In both countries, RSHO™ was the first cannabis product legally imported into the country. Classified as a prescription medication, Brazil and Mexico have subsidized the cost of RSHO™ CBD oil for patients in the countries.
The article reveals that interest in CBD oil online has nearly quadrupled in the past 5 years. HempMeds® and Medical Marijuana, Inc. are in a unique position to capitalize on this growing interest with their line of CBD oil products. Under brands like RSHO™, Dixie Botanicals®, Cannabis Beauty Defined®, and HempVAP®, the companies distribute CBD oil products all over the world.
Read the full article HERE.
Discover more about Medical Marijuana, Inc. and its portfolio of companies on our news feed.
